Agentix Corp Posts $408,526 Net Loss in First Nine Months of Fiscal 2026
Agentix Corp reported a net loss of $408,526 for the nine months ended December 31, 2025, compared with a loss of $385,280 in the prior-year period. The Nevada-based company's stockholders' deficit widened to $3.50 million.
Agentix Corp posted a net loss of $408,526 for the nine months ended December 31, 2025, up 6% from a loss of $385,280 in the same period a year earlier. The company reported no revenue for either period. Read more earnings reports.
Operating expenses climbed to $390,902 for the nine-month period, compared with $341,130 a year earlier, an increase of 15%. Interest expense more than doubled to $59,189 from $28,774 in the prior-year period.
For the three months ended December 31, 2025, Agentix narrowed its net loss to $78,595 from $143,894 in the year-earlier quarter. Operating expenses fell 30% to $67,463 from $96,815.
The company reported zero research and development expenses in the most recent quarter, down from $23,287 a year earlier. For the nine-month period, R&D spending increased to $125,079 from $90,638.
Balance Sheet and Cash Position
Total assets dropped to $6,396 as of December 31, 2025, down from $100,274 at the end of the prior fiscal year on March 31, 2025. Cash and cash equivalents stood at $6,396, compared with $4,477 nine months earlier.
The stockholders' deficit widened to $3.50 million from $3.10 million at fiscal year-end. Retained deficit expanded to $6.93 million from $6.52 million over the same period.
Total liabilities increased to $3.50 million from $3.20 million. Accounts payable declined to $707,215 from $968,888.
Cash Flow
Cash used in operations totaled $123,305 for the nine months ended December 31, 2025, compared with $82,020 in the prior-year period. The company reported no investing activity in either period.
Financing activities generated $110,450 in cash, up from $55,000 a year earlier.
| Metric | Nine Months Ended Dec 31, 2025 | Nine Months Ended Dec 31, 2024 |
|---|---|---|
| Net Loss | $408,526 | $385,280 |
| Operating Expenses | $390,902 | $341,130 |
| Interest Expense | $59,189 | $28,774 |
| R&D Expenses | $125,079 | $90,638 |
| Cash from Operations | ($123,305) | ($82,020) |
| Cash from Financing | $110,450 | $55,000 |
Agentix had 40,066,951 common shares outstanding as of December 31, 2025, unchanged from the prior fiscal year-end. The company is incorporated in Nevada and files as a non-accelerated filer.